Wilmer Cutler Pickering Hale and Dorr represented KALA BIO, Inc. in the transaction. KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company, announced it had entered into...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here